February 2022

Korsuva From Cara Therapeutics and Vifor Pharma

February 23, 2022

The FDA has approved Difelikefalin injection (Korsuva; Cara Therapeutics and Vifor Pharma) for the treatment of moderate-to-severe chronic kidney disease–associated pruritus in adults undergoing hemodialysis.